Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:46 am
Tags:
GLP-1 agonists, Novo Nordisk, Eli Lilly, obesity, weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
Tags:
insurance, weight loss, obesity, Eli Lilly, Novo Nordisk, Wegovy, Zepbound
Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices
Stat
Tue, 06/11/24 - 11:39 am
Tags:
Bernie Sanders, Novo Nordisk, Ozempic, Wegovy, drug pricing
Added health benefits of Wegovy, Zepbound could attract more men, doctors say
Reuters
Mon, 06/10/24 - 11:15 am
Tags:
Novo Nordisk, Wegovy, Eli Lilly, Zepbound, men's health, sleep apnea, heart disease
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China
Reuters
Wed, 06/5/24 - 10:29 pm
Tags:
Novo Nordisk, Ozempic, Wegovy, China, generics
Top ten biopharma R&D deals of 2024
Nature
Wed, 06/5/24 - 11:24 am
Tags:
R&D, Novartis, Argo Biopharmaceutical, Roche, MOMA Therapeutics, Boehringer Ingelheim, Suzhou Ribo Life Science, Eli Lilly, Isomorphic Labs, Merus, Gilead Sciences, Novo Nordisk, Neomorph, AbbVie, Umoja Biopharma, Merck KGaA, Caris Life Sciences, Voyager Therapeutics
Veeva Summit: Novo Nordisk’s ambitions for FPA to go live in one day
Clinical Trials Arena
Tue, 06/4/24 - 11:33 pm
Tags:
Veeva, Novo Nordisk, FPA, CROs, artificial intelligence
Novo Nordisk launches campaign for injectable weight-loss drug Wegovy
Medical Marketing and Media
Tue, 06/4/24 - 11:48 am
Tags:
Novo Nordisk, Wegovy, weight loss, obesity, DTC advertising
Weight loss drugs are so hard to find that this company built a tracker
Axios
Thu, 05/30/24 - 11:09 pm
Tags:
Novo Nordisk, Eli Lilly, Wegovy, Zepbound, weight loss, obesity, drug shortages, Ro
Novo attempts to parry Sanders' GLP-1 pricing complaints by calling out pharma middlemen
Fierce Pharma
Wed, 05/29/24 - 09:32 pm
Tags:
Novo Nordisk, Senate, drug pricing, GLP-1 agonists, Bernie Sanders
Weight-loss drug forecasts jump to $150 billion as supply grows
Reuters
Wed, 05/29/24 - 11:48 am
Tags:
Eli Lilly, Novo Nordisk, weight loss, Wegovy, Mounjaro
Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes
BioSpace
Tue, 05/28/24 - 11:00 am
Tags:
Novo Nordisk, insulin, insulin icodec, type 1 diabetes
Novo blames US health system after criticism over Wegovy price, Bloomberg reports
Reuters
Tue, 05/28/24 - 10:43 am
Tags:
Novo Nordisk, drug pricing, Ozempic, Wegovy, weight loss
Wegovy users have fewer kidney-related health problems, analysis of Novo study finds
Reuters
Sun, 05/26/24 - 12:29 pm
Tags:
Novo Nordisk, obesity, Wegovy
Novo Nordisk's Ozempic slows diabetic kidney disease progression in trial
Reuters
Fri, 05/24/24 - 11:30 am
Tags:
Novo Nordisk, Ozempic, kidney disease, diabetes, type 2 diabetes
FDA staff flags risk of low blood sugar for Novo Nordisk's weekly insulin
Reuters
Wed, 05/22/24 - 11:35 am
Tags:
Novo Nordisk, diabetes, FDA, insulin, hypoglycemia
Fire at Novo Nordisk office building under control
Reuters
Wed, 05/22/24 - 11:16 am
Tags:
Novo Nordisk, Denmark
Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins
CNBC
Tue, 05/21/24 - 07:11 pm
Tags:
Eli Lilly, Novo Nordisk, insulin, diabetes
Genetic profile may predict best response to weight-loss drug Wegovy
Reuters
Mon, 05/20/24 - 11:09 am
Tags:
Novo Nordisk, Wegovy, genetics, obesity, weight loss
Fire breaks out at Novo production hub: None injured and construction timelines likely unaffected, company says
Fierce Pharma
Fri, 05/17/24 - 11:19 am
Tags:
Novo Nordisk, drug manufacturing, Denmark

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.